145 related articles for article (PubMed ID: 18405337)
1. A study on the use of male animal models for developing a live vaccine for brucellosis.
Izadjoo MJ; Mense MG; Bhattacharjee AK; Hadfield TL; Crawford RM; Hoover DL
Transbound Emerg Dis; 2008 May; 55(3-4):145-51. PubMed ID: 18405337
[TBL] [Abstract][Full Text] [Related]
2. Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.
Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Hadfield TL; Hoover DL
Infect Immun; 2004 Jul; 72(7):4031-9. PubMed ID: 15213148
[TBL] [Abstract][Full Text] [Related]
3. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).
Hoover DL; Crawford RM; Van De Verg LL; Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Warren RL; Nikolich MP; Hadfield TL
Infect Immun; 1999 Nov; 67(11):5877-84. PubMed ID: 10531243
[TBL] [Abstract][Full Text] [Related]
4. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
5. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
6. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
[TBL] [Abstract][Full Text] [Related]
7. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
8. Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.
Clapp B; Skyberg JA; Yang X; Thornburg T; Walters N; Pascual DW
Infect Immun; 2011 Oct; 79(10):4165-74. PubMed ID: 21768283
[TBL] [Abstract][Full Text] [Related]
9. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine.
Bhattacharjee AK; Izadjoo MJ; Zollinger WD; Nikolich MP; Hoover DL
Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260
[TBL] [Abstract][Full Text] [Related]
10. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
[TBL] [Abstract][Full Text] [Related]
11. Vaccine Candidate Brucella melitensis 16M
Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
mSphere; 2020 May; 5(3):. PubMed ID: 32404509
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
13. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
[TBL] [Abstract][Full Text] [Related]
14. CD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis.
Yingst SL; Izadjoo M; Hoover DL
Clin Dev Immunol; 2013; 2013():686919. PubMed ID: 24288554
[TBL] [Abstract][Full Text] [Related]
15. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
16. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
Al-Mariri A; Abbady AQ
J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
[TBL] [Abstract][Full Text] [Related]
18.
Verdiguel-Fernández L; Oropeza-Navarro R; Ortiz A; Robles-Pesina MG; Ramírez-Lezama J; Castañeda-Ramírez A; Verdugo-Rodríguez A
J Microbiol Biotechnol; 2020 Apr; 30(4):497-504. PubMed ID: 31986561
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
20. Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.
Yang Y; Yin J; Guo D; Lang X; Wang X
FEMS Immunol Med Microbiol; 2011 Mar; 61(2):159-67. PubMed ID: 21166726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]